Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio's genome mining platform and its antibiotics discovery deal with Roche. "This is a big part ...

BOSTON, May 15, 2019 /PRNewswire/ -- Ginkgo Bioworks, the organism company, today announced it acquired the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines, Inc ...

Two papers in this issue present the results of large scale 'data mining' projects, in which the authors have used mouse genomic sequence databases to provide near-comprehensive descriptions of ...

Ginkgo Bioworks is buying Warp Drive Bio’s genome mining team, tech and database, eyeing the platform for use in next-generation antibiotics. Ginkgo has also taken on an antibiotics pact with ...

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate ...